Real-life studies in allergen immunotherapy

被引:12
作者
Passalacqua, Giovanni [1 ]
Bagnasco, Diego [1 ]
机构
[1] Univ Genoa, Allergy & Resp Dis, IRCCS Policlin San Martino, Lgo R Benzi 10, I-16133 Genoa, Italy
关键词
allergen immunotherapy; efficacy; real life; real world; safety; RANDOMIZED CONTROLLED-TRIALS; ADVERSE SYSTEMIC REACTIONS; SUBLINGUAL IMMUNOTHERAPY; EUROPEAN SURVEY; ASTHMA; RHINITIS; SAFETY; MANAGEMENT; EFFICACY; EASSI;
D O I
10.1097/ACI.0000000000000757
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Real-life (or real-world) studies can provide information that cannot be derived from randomized controlled trials. This approach is currently becoming of relevance for many treatments. In recent years, the real-life method has been applied also to allergen immunotherapy, providing new insights on it. We reviewed herein the available literature on the argument. Recent findings Several prospective and retrospective studies on allergen immunotherapy in the real-world setting have been published, mostly in the last 5 years. Most of them focused on adverse events, compliance, and the long term/preventive effects, and evidenced an overall favorable profile for different products and different allergens. Real life study provided novel information and evidenced those aspects of immunotherapy that worth a more detailed approach, without the strict limitations usually imposed by controlled randomized trials.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 37 条
[11]   European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment [J].
Calderon, M. A. ;
Vidal, C. ;
Rodriguez del Rio, P. ;
Just, J. ;
Pfaar, O. ;
Tabar, A. I. ;
Sanchez-Machin, I. ;
Bubel, P. ;
Borja, J. ;
Eberle, P. ;
Reiber, R. ;
Bouvier, M. ;
Lepelliez, A. ;
Klimek, L. ;
Demoly, P. .
ALLERGY, 2017, 72 (03) :462-472
[12]   An EAACI "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)": the methodology [J].
Calderon, Moises A. ;
Rodriguez del Rio, Pablo ;
Vidal, Carmen ;
Just, Jocelyne ;
Pfaar, Oliver ;
Linneberg, Allan ;
Demoly, Pascal .
CLINICAL AND TRANSLATIONAL ALLERGY, 2014, 4
[13]   Omalizumab management beyond clinical trials: The added value of a network model [J].
Caminati, Marco ;
Senna, Gianenrico ;
Bianchi, Fulvia Chieco ;
Marchi, Maria Rita ;
Vianello, Andrea ;
Micheletto, Claudio ;
Pomari, Carlo ;
Tognella, Silvia ;
Savoia, Francesca ;
Mirisola, Valentina ;
Rossi, Andrea .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 29 (01) :74-79
[14]   Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study [J].
Caruso, Cristiano ;
Brame, Barbara ;
Bagnasco, Diego ;
Cocconcelli, Alessia ;
Ortolani, Valeria ;
Pravettoni, Valerio ;
Scarpa, Sergio ;
Zisa, Giuliana ;
Passalacqua, Giovanni ;
Colantuono, Stefania .
BIOMED RESEARCH INTERNATIONAL, 2020, 2020
[15]   Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies? [J].
Devillier, Philippe ;
Demoly, Pascal ;
Molimard, Mathieu .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (05) :445-452
[16]   Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France [J].
Devillier, Philippe ;
Molimard, Mathieu ;
Ansolabehere, Xavier ;
Bardoulat, Isabelle ;
Coulombel, Nicolas ;
Maurel, Frederique ;
Le Jeunne, Philippe ;
Demoly, Pascal .
ALLERGY, 2019, 74 (07) :1317-1326
[17]   Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study [J].
Fernando Florido-Lopez, Jose ;
Andreu-Balaguer, Carmen ;
Escudero, Carmelo ;
Seoane-Rodriguez, Marta ;
Hernandez, Mercedes ;
Angel Navarro-Seisdedos, Luis ;
Torrecillas-Toro, Miguel ;
Anton-Girones, Monica ;
Herrero-Lifona, Leticia ;
Brugaletta, Dorimar ;
Macias, Jesus ;
Pineda, Rafael ;
Angeles Lara, Maria ;
Lopez-Caballero, Julian ;
Jose Rojas, Maria .
WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (12)
[18]   Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis [J].
Gerstlauer, Michael ;
Szepfalusi, Zsolt ;
Golden, David ;
Geng, Bob ;
de Blic, Jacques .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (01) :70-80
[19]   How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? [J].
Herland, K ;
Akselsen, JP ;
Skjonsberg, OH ;
Bjermer, L .
RESPIRATORY MEDICINE, 2005, 99 (01) :11-19
[20]   What you should not miss from the systematic reviews and meta-analyses on allergen-specific immunotherapy in 2017 [J].
Larenas-Linnemann, Desiree ;
Luna-Pech, Jorge A. .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 18 (03) :168-176